First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2029

Conditions
Mitral Valve Regurgitation
Interventions
DEVICE

Epygon™ Transcatheter Mitral Valve System

"The EPYGON VALVE is an innovative mitral valve, intended for valve replacement of a native mitral valve through a minimally invasive implant procedure by means of a dedicated implant device.~The EPYGON VALVE is a bio prosthesis, composed by a functional assembly of bovine pericardium on a NiTinol stent."

Trial Locations (10)

Unknown

RECRUITING

Medical University of Innsbruck, Innsbruck

RECRUITING

Medical University of Vienna - Department of Surgery, Division of Cardiac Surgery, Vienna

RECRUITING

Careggi Hospital Florence Italy Largo Brambilla, Florence

RECRUITING

A.O.U. Citta della Salute e della Scienza di Torino, Torino

NOT_YET_RECRUITING

Dedinje Cardiovascular Institute, Belgrade

RECRUITING

Hospital German Trias i Pujol, Badalona

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

RECRUITING

Hospital Clinico San Carlos, Madrid

RECRUITING

Hospital Virgen de la Arrixaca, Murcia

NOT_YET_RECRUITING

Hospital Universitario Virgen Del Rocio, Seville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Epygon

INDUSTRY

NCT04775108 - First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System | Biotech Hunter | Biotech Hunter